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ABSTRACT: 22	
Cirrhosis is a frequent and severe disease, complicated by renal sodium retention leading to ascites and oedema. 23	
A better understanding of the complex mechanisms responsible for renal sodium handling could improve clinical 24	
management of sodium retention. Our aim was to determine the importance of the amiloride-sensitive epithelial 25	
sodium channel (ENaC) in collecting ducts in compensate and decompensate cirrhosis.  26	
Bile duct ligation was performed in control mice (CTL) and collecting duct specific αENaC knock-out mice 27	
(KO), and ascites development, aldosterone plasma concentration, urinary sodium/potassium ratio and sodium 28	
transporter expression were compared.  29	
Disruption of ENaC in cortical collecting ducts (CCDs) did not alter ascites development, urinary 30	
sodium/potassium ratio, plasma aldosterone concentrations, or Na,K-ATPase abundance in CCDs. Total αENaC 31	
abundance in whole kidney increased in cirrhotic mice of both genotypes and cleaved forms of α and γ ENaC 32	
increased only in ascitic mice of both genotypes. The sodium chloride cotransporter (NCC) abundance was 33	
lower in non ascitic KO, compared to non ascitic CTL, and increased when ascites appeared.  34	
In ascitic mice, the lack of αENaC in CDs induced an upregulation of total ENaC and NCC and correlated with 35	
the cleavage of ENaC subunits. This revealed compensatory mechanisms which could also take place when 36	
treating the patients with diuretics. These compensatory mechanisms should be considered for future 37	
development of therapeutic strategies. 38	
 39	
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INTRODUCTION 42	
Cirrhosis is a frequent and severe disease, complicated by renal sodium retention leading to ascites and oedema. 43	
The development of the disease starts with damages to the liver architecture causing an increase of intrahepatic 44	
resistance and leading to portal hypertension. The latter is known to stimulate the production of nitric oxide, 45	
which in turn induces a peripheral arterial vasodilatation and causes intravascular volume insufficiency. This 46	
triggers mechanisms of sodium and water conservation through the renin-angiotensin-system, the sympathetic 47	
nervous system and the vasopressin pathway. It is hypothesized that an inadequate stimulation of these pathways 48	
leads to renal sodium retention which will favour ascites accumulation [13,25]. However, cellular and molecular 49	
mechanisms responsible for unbalanced renal sodium transport are incompletely understood. 50	
We showed previously, that bile duct-ligated mice developed ascites concomitantly to Na,K-ATPase stimulation 51	
in cortical collecting ducts exclusively [1]. Underlining the role of the aldosterone sensitive distal nephron in 52	
ascites development, studies performed with rats showed an increased apical targeting of ENaC in ascitic 53	
animals [20,21]. In order to investigate the role of collecting ducts (CDs) in cirrhosis-induced sodium retention, 54	
we used a transgenic mouse model with a CD-specific inactivation of the amiloride sensitive sodium channel 55	
(ENaC) [29], which is crucial for regulated renal sodium reabsorption. Rubera et al. showed that mice with 56	
disruption of αENaC in CDs were still able to maintain sodium and potassium balance, even when challenged by 57	
salt restriction, water deprivation, or potassium loading [29]. Our hypothesis was that in pathological conditions, 58	
such as cirrhosis, CD function may become of importance. 59	
The aim of the present study was to determine the importance of ENaC in CDs using the bile duct ligation-60	
induced cirrhosis mouse model. We investigated ascites development, plasma aldosterone concentrations, 61	
urinary sodium and potassium excretion, as well as the expression of ENaC subunits, sodium chloride co-62	
transporter (NCC) and Na,K-ATPase in control (CTL) and αENaC KO (KO) mice. 63	
 64	
SUBJECTS AND METHODS 65	
 66	
Animals 67	
 68	
Animal studies were approved by the Veterinary Service of the Canton de Vaud, Switzerland. Experiments were 69	
performed on adult CTL (Scnn1alox/lox) and αENaC KO (Hoxb7::cre/scnn1alox/lox) mice.  70	
 71	
Bile duct ligation  72	
 73	
The bile duct ligation was performed under anaesthesia mediated by isoflurane inhalation (57 CTL and 53 KO). 74	
A ventral incision was made; ligatures were tightened around the bile duct and the segment in between excised. 75	
The same procedure was performed in SHAM-operated mice (12 CTL and 10 KO) except that no ligatures were 76	
tightened. After ligation, abdominal muscles were sutured and skin closed with Michel’s suture clips. Mice were 77	
observed daily and received paracetamol (200 mg·kg-1·day-1) in drinking water for 2 days following surgery. 78	
 79	
Ascites quantitation 80	
 81	
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Ascites development was monitored by body weight measurement. The mice with or without ascites were 82	
determined a posteriori at the time of sacrifice; mice with ascites at the time of sacrifice were considered as mice 83	
BDL+  even ascites was not present yet. The rate of ascites accumulation was estimated by the calculation of 84	
bodyweight difference between a measurement and the previous one. 85	
 86	
Plasma aldosterone concentrations 87	
 88	
Plasma aldosterone concentrations were measured by RIA (Coat-a-Count; Diagnostics Products Inc.). 89	
 90	
Immunostaining 91	
 92	
Kidneys of anesthetized mice were fixed for 5 minutes with 3% PFA in phosphate buffer by retrograde perfusion 93	
via the abdominal aorta [22]. Kidneys were cut in thin sections, frozen in liquid propane and stored at -80°C 94	
until further analysis. Immunohistochemistry was performed on 4 µm cryosections. Sections were blocked with 95	
10% normal goat serum and subsequently incubated over night at 4°C with the primary antibodies (N-ter αENaC 96	
1/5000 [32]); followed by a Cy3-conjugated donkey anti-rabbit IgG (Jackson Immuno Research Laboratories) 97	
diluted 1/1000. The sections were analysed by a fluorescence microscope (Leica). Pictures were taken with a 98	
CCD-camera and processed with Adobe Photoshop and Microsoft PowerPoint softwares. 99	
 100	
Urine collection 101	
 102	
Mice were installed into restraining tube, every 3 to 4 days from 8:00 am to 11:00 am, for urine collection. 103	
Urinary sodium and potassium were measured by flame photometry (IL943, Instrumentation Laboratory). 104	
 105	
Microdissection of renal tubules 106	
 107	
The left kidney was perfused with a liberase containing solution (liberase TM 33 µg/ml from Roche in 108	
DMEM/F-12, 1:1; Invitrogen). Pyramids cut along the corticomedullary axis were incubated at 30°C for 40 min 109	
in perfusion medium. Tubules were isolated in ice-cold DMEM/F-12 supplemented with 0.05% BSA without 110	
liberase. Tubules were transferred into 96 well plates and photographed. The total length of tubules was 111	
measured using Image J [31].  112	
 113	
Na,K-ATPase Assay 114	
 115	
Na,K-ATPase activity was determined as previously described [5]. Total ATPase activity was determined in a 116	
solution containing 50 mM NaCl, 5 mM KCl, 10 mM MgCl2, 1 mM EGTA, 100 mM Tris-HCl, 10 mM Na2ATP, 117	
and 8 nCi/µl of ATP [γ-32P] (10 Ci/mmol, 2 mCi/ml, Perkin Elmer: BLU002250UC) at pH 7.4. For Na+, K+-118	
independent ATPase activity measurements, NaCl and KCl were omitted, Tris-HCl was 150 mM, and 2 mM 119	
ouabain was added. Na,K-ATPase activity was taken as the difference between total and Na+, K+-independent 120	
ATPase activities and expressed as the mean in pmole·mm-1·hour-1 of n measurements. 121	
4	
	
 122	
SDS-PAGE and Immunoblotting 123	
 124	
Kidneys were homogenized using a Dounce tissue grinder and membrane proteins extracted in presence of 125	
protease and phosphatase inhibitors (No. 78440, Pierce) according to the manufacturer protocol (MEM Per Plus 126	
Kit No. 89842, Pierce). Protein concentration was quantified using the BCA protein assay kit (No. 23225, 127	
Pierce). Ten microgram were separated by SDS-PAGE, then transferred on nitrocellulose membrane and stained 128	
with Ponceau red before immunodetection. Nitrocellulose membranes were incubated with primary antibodies 129	
detecting, αENaC (1/10000) [32], βENaC (1/10000) [33] and γENaC (1/10000) [33] and NCC (1/10000) [32]. 130	
Immunoblots were scanned using the Molecular Imager Chemidoc XRS+ (Biorad). Relative quantification was 131	
obtained by dividing the densitometric values of the proteins of interest by the densitometric values obtained 132	
with Ponceau red staining for the corresponding lane. 133	
 134	
Total RNA extraction and qPCR 135	
 136	
Total RNA was extracted from kidneys with Trizol according manufacturer’s protocol (Life Technologies). 137	
Reverse transcription was performed on 1 µg of total RNA with the ImProm-II™ Reverse Transcription System 138	
(Promega). Relative abundances of transcripts were calculated after qPCR amplification. Primers and probes 139	
number - corresponding to the Universal ProbeLibrary (Roche) - targeting transcripts of interest, described in 140	
table 1, were designed using ProbeFinder software (Roche). 141	
 142	
Statistics 143	
 144	
Results are expressed as means ± SEM from several animals. To determine statistically significant differences, 145	
Student t-test or 1- or 2-way analysis of variance were used, followed by Bonferroni’s tests for multiple 146	
comparisons. 147	
 148	
RESULTS 149	
 150	
Control and collecting duct alpha ENaC KO mice develop ascites 151	
 152	
The presence of ascites was a prerequisite to identify cirrhotic mice with sodium retention. Ascites development 153	
was indirectly estimated by body weight measurement (Fig. 1A and B). Around ten days after BDL, 30% of 154	
CTL (17 out of 57) and 36% of KO (18 out of 53) of bile duct-ligated mice rapidly gained weight due to ascites 155	
accumulation (BDL+). Mice were sacrificed when ascites was observed for several consecutive days. The 156	
proportion of mice developing ascites and their survival rate after bile duct ligation were not affected by the 157	
genotype (Fig. 1C). Ascites accumulated at 1 ml per day and its volume reached about 10 ml at the time of 158	
sacrifice (Fig. 1D). Mice which did not gain weight (BDL-) over a period of 20 to 30 days after BDL were 159	
sacrificed and considered to be mice with compensated cirrhosis (BDL-).  160	
 161	
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Immunolocalization confirms αENaC disruption in CDs 162	
 163	
Deletion of αENaC along collecting ducts (CDs) of αENaC KO mice was assessed by immunostaining (Fig. 2). 164	
In CTL mice, αENaC was seen in all principal cells of CDs, independent from the group (SHAM, BDL-, and 165	
BDL+). In KO mice, αENaC was absent from CD cells. A very few principal cells with remaining αENaC 166	
expression were seen in the initial cortical collecting duct. 167	
 168	
Urinary sodium and potassium excretion are similar in CTL and αENaC KO mice 169	
 170	
As expected in mice retaining sodium, 2-way analysis of variance with presence of ascites (BDL- vs BDL+) and 171	
genotype as a factor revealed a significant reduction of the urinary Na+/Creatinine as well as Na+/K+ ratio in 172	
BDL+ (p = 0.0133 and p = 0.0217 respectively), which  was not affected by the genotype (Fig. 3A).  173	
 174	
Plasma aldosterone concentrations increase in CTL and αENaC KO mice with ascites 175	
 176	
Plasma aldosterone concentrations increased independently of genotypes following bile duct ligation. A 2-way 177	
analysis of variance of aldosterone plasma concentrations between SHAM, BDL- and BDL+ revealed a 178	
significant increase in BDL+ mice (Fig. 3B).  179	
 180	
ENaC is upregulated in cirrhotic CTL and KO mice 181	
 182	
Immunoblots on membrane proteins extracted from kidney homogenates showed increased αENaC abundance in 183	
cirrhotic mice (BDL- or BDL+) (Fig. 4A). The cleaved form of αENaC appeared as doublets, as previously 184	
observed by others [6,10,11]. Statistical analysis of band density quantifications revealed (Fig. 4B) an 185	
upregulation of total αENaC (full and cleaved forms) in ascitic KO mice and interestingly a greater abundance of 186	
αENaC in KO BDL+ vs CTL BDL+ mice. Analysis of the full form showed an increase in BDL- and BDL+ 187	
mice, with no differences between genotypes (Fig. 4C). An increase of the αENaC cleaved form was observed in 188	
ascitic mice; however it was significant only in the KO BDL+ likely due to the variability observed in CTL 189	
BDL+ mice. The abundance of the cleaved form was higher in KO BDL+ versus CTL BDL+ (p < 0.01) (Fig. 190	
4D). The abundance of transcript coding for ENaC (scnn1a) was affected in BDL+ mice independently of 191	
genotypes (Fig. 4E).  192	
The expression of βENaC subunit (Fig. 5A) was not altered in CTL BDL- and CTL BDL+ mice, but was 193	
increased in KO BDL- mice (Fig. 5B). The abundance of transcript coding for ENaC (scnn1a) was affected in 194	
BDL+ mice independently of genotypes (Fig. 5C). 195	
Immunoblots showed a higher abundance of the γENaC cleaved form compared to its full form for two CTL 196	
BDL+ and KO BDL+ mice and the quasi absence of the γENaC cleaved form in BDL- (Fig. 6A). The full 197	
γENaC is les abundant in BDL+ than in BDL+ in both genotypes (Fig. 6C) while γENaC cleaved form is more 198	
abundant in BDL+ than in BDL- mice (Fig. 6D). The abundance of transcript coding for ENaC (scnn1a) was 199	
affected in BDL+ mice independently of genotypes (Fig. 6E). 200	
 201	
6	
	
The absence of ENaC activity in collecting ducts does not influence Na,K-ATPase abundance 202	
 203	
Previously used as a marker for sodium reabsorption along renal tubules [1], the Na,K-ATPase activity 204	
measurements performed in microdissected tubules at Vmax reflects the abundance of Na,K-ATPase holoenzyme. 205	
In this study, the measurements did not reveal differences between groups (Fig. 7). 206	
 207	
Sodium chloride costransporter abundance differs between CTL and KO cirrhotic mice 208	
 209	
Immunoblots on membrane proteins extracted from whole kidney showed reduced NCC abundance in BDL- 210	
mice (Fig. 8A). Statistical analysis of band density quantification showed a downregulation of NCC in cirrhotic 211	
CTL BDL+ and KO BDL- (Fig. 8B). Since samples from CTL and KO were loaded on different gels, and thus 212	
could not be compared, we did a second electrophoresis to investigate differences between CTL and KO samples 213	
in SHAM, BDL- and BDL+ (Fig. 9A and B). This revealed a lower NCC abundance in KO BDL- than in CTL 214	
BDL-, and a higher abundance in KO BDL+ than in CTL BDL+ mice. The abundance of its transcript was not 215	
altered (Fig. 8C). 216	
 217	
DISCUSSION 218	
 219	
To our knowledge, this is the first study investigating the mechanisms of sodium retention by bile duct ligation 220	
in genetically modified animals. It demonstrated in ascitic mice that the disruption of ENaC and thus a lack of its 221	
activity in CDs induced ENaC and NCC in upstream segments. These results on ENaC expression are in line 222	
with previous studies demonstrating the importance of ENaC in CNTs for the regulation of sodium reabsorption 223	
[9,12,27].  224	
The absence of ENaC in CDs did not alter ascites formation. It developed in 30% of CTL and 36% of KO bile 225	
duct-ligated mice. 226	
The immunohistochemical studies confirmed the disruption of ENaC in CDs of KO mice. Although a very few 227	
single cells in cortical collecting ducts escape the cre recombinase mediated inactivation of αENaC, as 228	
previously reported [29], we consider it highly unlikely that these few single CD-cells with persistent αENaC 229	
expression can account for the absence of differences between CTL and KO mice. It is likely that upstream 230	
segments contribute to sodium retention.  231	
The urinary Na+/Creatinine as well as Na+/K+ ratios were reduced and plasma aldosterone concentrations 232	
increased in BDL+, as observed in humans [4].  233	
Western blot analysis showed for both genotypes, an increase of αENaC abundance in BDL- and BDL+, but it 234	
also revealed that the cleavage of α and γ subunits was significant only in BDL+ mice, which were retaining 235	
sodium. In kidneys, αENaC protein abundance has been shown to be regulated by aldosterone, while βENaC and 236	
γENaC not or only weakly [6,26]. Moreover, aldosterone stimulation or low salt diet was shown to induce an 237	
apical redistribution of αENaC, βENaC and γENaC [8,10,23,24,26] and cleavage of αENaC and γENaC [6,26]. 238	
Cleavage of ENaC by exogenous trypsin has been linked to an increase of channel activity [8,28]. Kim et al. 239	
observed, in ascitic rats, an increased apical targeting of αβγENaC in DCTs, CNTs and CDs, and cleavage of 240	
γENaC, without changes of αβγENaC protein abundance [21,20].  Altogether these results showed that in ascitic 241	
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animals, α and γ ENaC are cleaved, suggesting an increase in ENaC activity and thus demonstrate its importance 242	
for sodium retention. Interestingly, in our study, the αENaC cleaved form was more abundant in KO BDL+ than 243	
in CTL BDL+ mice, suggesting insufficient sodium reabsorption and a need to compensate.  244	
We did not observe increase in NCC abundance, although NCC is described as an aldosterone induced protein 245	
[19]. The slight decrease in NCC abundance observed in CTL cirrhotic mice was not significant in contrast to 246	
what was previously reported [7,14,34]. In BDL- mice NCC protein expression was lower than in CTL, whereas 247	
in BDL+ mice, in which sodium retention occurs it was higher in KO than CTL mice and probably reached the 248	
same level as in the SHAM operated mice as shown by the results in fig. 8. These results suggested 249	
compensation by NCC of an insufficient ENaC activity in CDs. The reduced abundance of NCC in non ascitic 250	
mice may reflect the aldosterone escape phenomenon, characterized by a downregulation of NCC in presence of 251	
high plasma aldosterone concentrations and high salt diet [30]. Conditions which are similar to those 252	
encountered by the CTL cirrhotic mice; their plasma aldosterone concentrations are high and their salt intake 253	
sufficient. The downregulation of NCC could also be due to an increase in plasma potassium concentration [3]. 254	
However, this hypothesis is unlikely since several studies performed in rats reported normal plasma potassium 255	
values in cirrhotic animals [14,15,17,18].  256	
In contrast to Ackermann et al., we did not observe any significant up-regulation of the Na,K-ATPase activity in 257	
isolated CCDs between SHAM-operated and cirrhotic mice [1]. This difference could be due to the mouse 258	
strains used. In the previous study, CD1 mice were used whereas in the actual one, we used 129/Sv x C57BL/6, 259	
since they are more prone to develop ascites [2]. Additionally mice were analysed at different time point. 260	
In summary, our study showed that in pathological conditions such as cirrhosis, the amount of sodium 261	
reabsorbed through ENaC in CDs is likely not negligible and if not sufficient, NCC upregulation may happen. 262	
The upregulation of NCC could explain the blunted natriuretic effect of the amiloride observed in cirrhotic rats 263	
treated with amiloride [16]. 264	
The control of renal sodium retention and ascites development is not trivial in cirrhotic patients. A better 265	
understanding of the mechanisms responsible for renal sodium handling would improve its clinical management. 266	
This study illustrates the usability of gene-modified mouse models to dissect the complex mechanisms of sodium 267	
retention. It revealed compensation mechanisms which could take place when we downregulate artificially ion 268	
transporters, similarly as what is done with diuretics. In conclusion, to develop efficient therapeutic strategies, 269	
we have to understand pathways leading to sodium/potassium imbalance and to further consider compensatory 270	
mechanisms. 271	
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FIGURES LEGENDS 405	
 406	
Fig. 1 407	
Evolution of body weight (mean ± SEM) after bile duct ligation of CTL (A) or αENaC KO (B) mice without 408	
(BDL-) and with (BDL+) ascites. Fate of mice after bile duct ligation: a 2-sample test for equality of proportions 409	
showed no differences between genotypes regarding ascites development (C). Indirect quantification of ascites 410	
accumulation rate (mean ± SEM) 6 CTL and 5 KO mice (D).  411	
 412	
Fig. 2 413	
Renal immunolocalization of αENaC for SHAM, BDL- and BDL+ mice. Collecting ducts (C), proximal tubules 414	
(P). 415	
 416	
Fig. 3 417	
Urinary Na+, K+ / Creatinine and Na+/K+ ratio and plasma aldosterone concentrations. Urinary Na+/Creatinine is 418	
reduced in BDL+ mice (Fig 3A). 2-way ANOVA, with presence of ascites and genotype as factors; the 419	
difference between BDL- and BDL+ is significant (p = 0.0217); neither the genotype nor the interaction is 420	
significant. Urinary K+/Creatinine is similar between BDL- and BDL+. Urinary Na+/ K+ ratio (mean ± SEM) of 421	
CTL and KO mice: without ascites, more than 2 weeks after bile duct ligation (BDL-) and with ascites, more 422	
than 2 weeks after bile duct ligation (BDL+). 2-way ANOVA, with presence of ascites and genotype as factors; 423	
the difference between BDL- and BDL+ is significant (p = 0.0133); neither the genotype nor the interaction is 424	
significant. Aldosterone plasma concentrations (mean ± SEM) of CTL and KO mice: sham-operated (SHAM); 425	
without (BDL-) and with (BDL+) ascites (B). A Bonferroni’s post test showed that the BDL+ groups (CTL or 426	
KO) are significantly different from their respective SHAM groups (p < 0.0001 in both cases); the difference 427	
between SHAM and BDL- group is not significant. 428	
 429	
Fig. 4 430	
αENaC abundance. Membrane protein extracts from whole kidneys from CTL (n=4) and KO (n=4) mice were 431	
loaded on a single 10% polyacrylamide gel (A) and quantified. 2-way ANOVA with health status (Healthy mice, 432	
SHAM, without ascites, BDL- and with ascites, BDL+) and genotype as factors, followed by Bonferroni’s post-433	
test revealed significant differences (*) in the abundance of the total αENaC protein (B): KO SHAM vs KO 434	
BDL+, p < 0.0001; KO BDL- vs KO BDL+, p = 0.0017; CTL BDL+ vs KO BDL+ p = 0.0096; for the 435	
abundance of the full αENaC protein: CTL SHAM vs CTL BDL-, p = 0.0107 (C); KO SHAM vs KO BDL-, p = 436	
0.0498; KO SHAM vs KO BDL+, p = 0.0025; and in the αENaC cleaved protein (D): KO SHAM vs KO BDL-, 437	
p = 0.0005; KO SHAM vs KO BDL+, p = 0.0014; CTL BDL+ vs KO BDL+, p = 0.018. A 2-way ANOVA 438	
revealed a significant difference for scnn1a abundance between SHAM and BDL+ (p = 0.0133), but neither the 439	
genotype nor the interaction were significant (E). 440	
 441	
Fig. 5 442	
βENaC abundance. Membrane protein extracts from whole kidneys from CTL (n=4) and KO (n=4) mice were 443	
loaded on a single 10% polyacrylamide gel (A) and quantified (B). 2-way ANOVA with health status (Healthy 444	
12	
	
mice, SHAM, without ascites, BDL- and with ascites, BDL+) and genotype as factors, followed by Bonferroni’s 445	
post-test revealed significant differences (*) in the abundance of the βENaC protein (B): KO SHAM vs KO 446	
BDL-, p < 0.0003; KO BDL- vs KO BDL+, p = 0.0001; CTL BDL- vs KO BDL- p = 0.0375 (B). A 2-way 447	
ANOVA revealed a significant difference for scnn1b abundance between SHAM and BDL+ (p = 0.0185), but 448	
neither the genotype nor the interaction were significant (C). 449	
 450	
Fig. 6 451	
γENaC abundance. Membrane protein extracts from whole kidneys CTL (n=4) of and KO (n=4) of mice were 452	
loaded on two different 4-20% polyacrylamide gels (A). Since samples from CTL and KO were not loaded on 453	
the same gel, only a 1-way ANOVA was possible: No differences were seen in the total γENaC protein (full and 454	
cleaved) (B); Significant differences were revealed for the abundance of the full γENaC protein: CTL BDL- vs 455	
CTL BDL+, adj. p = 0.0134; KO BDL- vs KO BDL+, adj. p = 0.0243 (C); and in the γENaC cleaved protein 456	
(D): CTL BDL- vs CTL BDL+, adj. p = 0.044; KO BDL- vs KO BDL+, adj. p = 0.0098. A 2-way ANOVA 457	
revealed a significant difference for scnn1a abundance between SHAM and BDL+ (p = 0.0133), but neither the 458	
genotype nor the interaction were significant (E). 459	
 460	
Fig. 7 461	
Na,K-ATPase abundance in cortical collecting ducts. Na,K-ATPase abundance was quantified by measuring the 462	
Na,K-ATPase activity at Vmax in microdissected CCDs from CTL and collecting ducts specific αENaC KO mice 463	
for the 3 groups: SHAM-operated, without ascites (BDL-) and with (BDL+). Values represent the means ± SEM 464	
from 3 to 7 mice. The number into the columns represents the n. 465	
 466	
Fig. 8 467	
NCC abundance: Comparison between SHAM, BDL- and BDL+. Membrane protein extracts from whole 468	
kidneys of CTL and KO were loaded on a 10% polyacrylamide gel (A) and quantified (B). Since samples from 469	
CTL and KO were not loaded on the same gel, only a 1-way ANOVA was possible: Significant differences were 470	
revealed for the abundance of NCC in the KO group: SHAM vs BDL-, p = 0.0287 and BDL- vs BDL+, p = 471	
0.0075. No difference in the relative sl12a3 (NCC) abundance (C). 472	
 473	
Fig. 9 474	
NCC abundance: Comparison between CTL and KO. Membrane protein extracts from whole kidneys SHAM, 475	
BDL- and BDL+ were loaded on a 10% polyacrylamide gel (A) and quantified (B). Significant differences were 476	
revealed for the abundance of NCC in cirrhotic mice, by Student t-test followed by Mann-Whitney post-test: 477	
CTL BDL- vs KO BDL-, p < 0.01 and CTL BDL+ vs KO BDL+, p < 0.01. 478	
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